Mercer Global Advisors »

Supernus Pharmaceuticals shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $327k 11k 28.93
2023-09-30 $313k 11k 27.58
2023-06-30 $345k 12k 30.04
2023-03-31 $377k 10k 36.19
2022-12-31 $362k 10k 35.65
2022-09-30 $431k 13k 33.87
2022-06-30 $353k 12k 28.90
2022-03-31 $394k 12k 32.34
2021-12-31 $287k 9.8k 29.17
2021-09-30 $254k 9.5k 26.67
2021-06-30 $303k 9.8k 30.80